Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis. [electronic resource]
Producer: 20020124Description: 290-6 p. digitalISSN:- 0020-7136
- Animals
- Anti-Bacterial Agents -- pharmacology
- Antibiotics, Antineoplastic -- pharmacology
- Antineoplastic Agents -- pharmacology
- Aorta -- metabolism
- Cattle
- Cell Adhesion
- Cell Division
- Cell Movement
- Cells, Cultured
- Chick Embryo
- Clinical Trials as Topic
- Collagen -- pharmacology
- DNA, Complementary -- metabolism
- Depsipeptides
- Dose-Response Relationship, Drug
- Drug Combinations
- Endothelium, Vascular -- cytology
- Enzyme Inhibitors -- pharmacology
- Female
- HeLa Cells
- Histone Deacetylase Inhibitors
- Histone Deacetylases -- metabolism
- Humans
- Laminin -- pharmacology
- Ligases -- metabolism
- Male
- Mice
- Mice, Inbred C57BL
- Neoplasm Invasiveness
- Neovascularization, Pathologic
- Neurofibromin 2 -- metabolism
- Peptides, Cyclic
- Proteoglycans -- pharmacology
- Reverse Transcriptase Polymerase Chain Reaction
- Transcription, Genetic
- Tumor Suppressor Proteins
- Ubiquitin-Protein Ligases
- Von Hippel-Lindau Tumor Suppressor Protein
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.